April 02, 2020 - 3:00 PM - 4:00 PM

FDLI’s Regenerative Medicine: Regulatory, Enforcement, and Legal Challenges for Cell and Gene Therapies Conference

Regenerative Medicine: Regulatory, Enforcement, and Legal Challenges for Cell and Gene Therapies at FDLI

This event has already occurred.
Webinar

Venable attorney Todd Halpern will present “Enforcement Trends” at FDLI’s Regenerative Medicine: Regulatory, Enforcement, and Legal Challenges for Cell and Gene Therapies conference on April 2, 2020. This panel will explore lessons learned from FDA’s completed and ongoing enforcement actions and litigation against cell therapy companies. Speakers will also discuss FDA’s compliance assistance programs and projected agency steps after the November 2020 enforcement discretion deadline, as well as the potential public health effects of Google’s recent decision to stop advertising unapproved stem cell therapies.

If you want to learn more, please visit the event website here.